CPHI vs HON · rev $4.5M vs P/E 36, rev $9.72B
China Pharma Holdings Inc (CPHI) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
CPHI currently screens at market cap $29.0M. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the CPHI and HON stock pages for the full models.
Not investment advice.